Hyponatremia in heart failure: not just 135 to 145
-
Denny Suwanto
,
Ivana Purnama Dewi
und
Rosi Amrilla Fagi
Abstract
One of the most frequent in-hospital electrolyte disturbances is hyponatremia. Hyponatremia in heart failure (HF) is mainly associated with hypervolemia resulting from activation of baroreceptor-mediated hormones, such as arginine vasopressin (AVP), renin–angiotensin–aldosterone system, and catecholamines. Various electrolyte imbalance can occur as heart failure progress. The goal of this review was to outline the current literature on hyponatremia in HF patients.
-
Research funding: None declared.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Not applicable.
-
Ethical approval: Not applicable.
References
1. Berl, T, Henrich, W. Kidney-heart interactions: epidemiology, pathogenesis, and treatment. Clin J Am Soc Nephrol 2006;1:8–18. https://doi.org/10.2215/cjn.00730805.Suche in Google Scholar PubMed
2. Parmar, AM, Dosi, RV, Raghapriya, R. Dysnatremia in cardiac failure. Int J Med Res 2018;3:93–6.Suche in Google Scholar
3. Klein, L, O’Connor, CM, Leimberger, JD, Gattis-Stough, W, Piña, IL, Felker, GM, et al.. Lower serum natrium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure (OPTIME-CHF) study. Circulation 2005;111:2454–60. https://doi.org/10.1161/01.cir.0000165065.82609.3d.Suche in Google Scholar
4. Rossi, J, Bayram, M, Udelson, JE, Lloyd-Jones, D, Adams, KF, Oconnor, CM, et al.. Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the acute and chronic therapeutic impact of a vasopressin antagonist in chronic heart failure (ACTIV in CHF) trial. Acute Card Care 2007;9:82–6. https://doi.org/10.1080/17482940701210179.Suche in Google Scholar PubMed
5. Tepper, D, Harris, S, Ip, R. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE trial. Congest Heart Fail 2008;14:46. https://doi.org/10.1111/j.1751-7133.2008.07773.x.Suche in Google Scholar
6. Abraham, WT, Fonarow, GC, Albert, NM, Stough, WG, Gheorghiade, M, Greenberg, BH, et al.. Predictors of in-hospital mortality in patients hospitalized for heart failure. Insights from the organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF). J Am Coll Cardiol 2008;52:347–56. https://doi.org/10.1016/j.jacc.2008.04.028.Suche in Google Scholar PubMed
7. Romanovsky, A, Bagshaw, S, Rosner, MH. Hyponatremia and congestive heart failure: a marker of increased mortality and a target for therapy. Int J Nephrol 2011;2011:1–7. https://doi.org/10.4061/2011/732746.Suche in Google Scholar PubMed PubMed Central
8. Hao, J, Li, Y, Zhang, X, Pang, C, Wang, Y, Nigwekar, SU, et al.. The prevalence and mortality of hyponatremia is seriously underestimated in Chinese general medical patients: an observational retrospective study. BMC Nephrol 2017;18:328. https://doi.org/10.1186/s12882-017-0744-x.Suche in Google Scholar PubMed PubMed Central
9. Abebe, TB, Gebreyohannes, EA, Tefera, YG, Bhagavathula, AS, Erku, DA, Belachew, SA, et al.. The prognosis of heart failure patients: does natrium level play a significant role?. PLoS One 2018;13: e0207242. https://doi.org/10.1371/journal.pone.0207242.Suche in Google Scholar PubMed PubMed Central
10. Rusinaru, D, Tribouilloy, C, Berry, C, Richards, AM, Whalley, GA, Earle, N, et al.. Relationship of serum natrium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis: Mata-Analysis Global Group in Chronis heart failure (MAGGIC). Eur J Heart Fail 2012;14:1139–46. https://doi.org/10.1093/eurjhf/hfs099.Suche in Google Scholar PubMed
11. Bers, DM, Chen-Izu, Y. Natrium and calcium regulation in cardiac myocytes: from molecules to heart failure and arrhythmia. J Physiol 2015;593:1327–9. https://doi.org/10.1113/jp270133.Suche in Google Scholar
12. Movafagh, S, Cleemann, L, Morad, M. Regulation of cardiac Ca2+ channel by extracellular Na+. Cell Calcium 2011;49:162–73. https://doi.org/10.1016/j.ceca.2011.01.008.Suche in Google Scholar
13. Urso, C, Brucculeri, S, Caimi, G. Acid–base and electrolyte abnormalities in heart failure: pathophysiology and implications. Heart Fail Rev 2015;20:493–503. https://doi.org/10.1007/s10741-015-9482-y.Suche in Google Scholar
14. Kalra, P. Water and natrium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin. Cardiovasc Res 2001;51:495–509. https://doi.org/10.1016/s0008-6363(01)00297-8.Suche in Google Scholar
15. Liamis, G, Milionis, HJ, Elisaf, M. A review of drug-induced hypernatraemia. Clin Kidney J 2009;2:339–46. https://doi.org/10.1093/ndtplus/sfp085.Suche in Google Scholar
16. Assen, Sv, Mudde, AH. Severe hyponatraemia in an amiloride/hydrochlorothiazide-treated patient. Neth J Med 1999;54:108–13. https://doi.org/10.1016/s0300-2977(98)00153-3.Suche in Google Scholar
17. Gheorghiade, M, Abraham, WT, Albert, NM, Stough, WG, Greenberg, BH, O’Connor, CM, et al.. Relationship between admission serum natrium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J 2007;28:980–8. https://doi.org/10.1093/eurheartj/ehl542.Suche in Google Scholar PubMed
18. Bettari, L, Fiuzat, M, Shaw, LK, Wojdyla, DM, Metra, M, Felker, GM, et al.. Hyponatremia and long-term outcomes in chronic heart failure - an observational study from the duke databank for cardiovascular diseases. J Card Fail 2012;18:74–81. https://doi.org/10.1016/j.cardfail.2011.09.005.Suche in Google Scholar PubMed
19. Kirchhof, P, Benussi, S, Zamorano, JL, Aboyans, V, Achenbach, S, Agewall, S, et al.. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2017;37:2893–962. https://doi.org/10.1093/eurheartj/ehw210.Suche in Google Scholar PubMed
20. Sato, N, Gheorghiade, M, Kajimoto, K, Munakata, R, Minami, Y, Mizuno, M, et al.. Hyponatremia and in-hospital mortality in patients admitted for heart failure (from the ATTEND Registry). Am J Cardiol 2013;111:1019–25. https://doi.org/10.1016/j.amjcard.2012.12.019.Suche in Google Scholar PubMed
21. Deubner, N, Berliner, D, Frey, A, Güder, G, Brenner, S, Fenske, W, et al.. Dysnatraemia in heart failure. Eur J Heart Fail 2012;14:1147–54. https://doi.org/10.1093/eurjhf/hfs115.Suche in Google Scholar PubMed
22. Vazquez, R, Bayes-Genis, A, Cygankiewicz, I, Pascual-Figal, D, Grigorian-Shamagian, L, Pavon, R, et al.. The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure. Eur Heart J 2009;30:1088–96. https://doi.org/10.1093/eurheartj/ehp032.Suche in Google Scholar PubMed
23. Madan, VD, Novak, E, Rich, MW. Impact of change in serum natrium concentration on mortality in patients hospitalized with heart failure and hyponatremia. Circ Heart Failure 2011;4:637–43. https://doi.org/10.1161/circheartfailure.111.961011.Suche in Google Scholar PubMed
24. Konishi, M, Haraguchi, G, Ohigashi, H, Sasaoka, T, Yoshikawa, S, Inagaki, H, et al.. Progression of hyponatremia is associated with increased cardiac mortality in patients hospitalized for acute decompensated heart failure. J Card Fail 2012;18:620–5. https://doi.org/10.1016/j.cardfail.2012.06.415.Suche in Google Scholar PubMed
25. Krumholz, HM, Chen, YT, Bradford, WD, Cerese, J. Variations in and correlates of length of stay in academic hospitals among patients with heart failure resulting from systolic dysfunction. Am J Manag Care 1999;5:715–23.Suche in Google Scholar
26. Zilberberg, MD, Exuzides, A, Spalding, J, Foreman, A, Jones, AG, Colby, C, et al.. Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients. Curr Med Res Opin 2008;24:1601–8. https://doi.org/10.1185/03007990802081675.Suche in Google Scholar PubMed
27. Goldsmith, SR, Gheorghiade, M. Vasopressin antagonism in heart failure. J Am Coll Cardiol 2005;46:1785–91. https://doi.org/10.1016/j.jacc.2005.02.095.Suche in Google Scholar PubMed
28. Schrier, RW, Gross, P, Gheorghiade, M, Berl, T, Verbalis, JG, Czerwiec, FS, et al.. Tolvaptan, a selective oral vasopressin V 2 -receptor antagonist, for hyponatremia. N Engl J Med 2006;355:2099–112. https://doi.org/10.1056/nejmoa065181.Suche in Google Scholar PubMed
29. Dzau, VJ, Hollenberg, NK. Renal response to captopril in severe heart failure: role of furosemide in natriuresis and reversal of hyponatremia. Ann Intern Med 1984;100:777–82. https://doi.org/10.7326/0003-4819-100-6-777.Suche in Google Scholar PubMed
30. Licata, G, Pasquale, PD, Parrinello, G, Cardinale, A, Scandurra, A, Follone, G, et al.. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Am Heart J 2003;145:459–66. https://doi.org/10.1067/mhj.2003.166.Suche in Google Scholar PubMed
31. Udelson, JE, Orlandi, C, Ouyang, J, Krasa, H, Zimmer, CA, Frivold, G, et al.. Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: an international, multicenter, randomized, placebo-controlled trial. J Am Coll Cardiol 2008;52:1540–5. https://doi.org/10.1016/j.jacc.2008.08.013.Suche in Google Scholar PubMed
32. Watanabe, K, Dohi, K, Sugimoto, T, Yamada, T, Sato, Y, Ichikawa, K, et al.. Short-term effects of low-dose tolvaptan on hemodynamic parameters in patients with chronic heart failure. J Cardiol 2012;60:462–9. https://doi.org/10.1016/j.jjcc.2012.09.002.Suche in Google Scholar PubMed
33. Udelson, JE, McGrew, FA, Flores, E, Ibrahim, H, Katz, S, Koshkarian, G, et al.. Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction. J Am Coll Cardiol 2017;49:2151–9. https://doi.org/10.1016/j.jacc.2007.01.091.Suche in Google Scholar PubMed
34. Konstam, MA, Gheorghiade, M, Burnett, JC, Grinfeld, L, Maggioni, AP, Swedberg, K, et al.. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. J Am Med Assoc 2007;297:1319–31. https://doi.org/10.1001/jama.297.12.1319.Suche in Google Scholar PubMed
35. Braun, MM, Barstow, CH, Pyzocha, NJ. Diagnosis and management of sodium disorders: hyponatremia and hypernatremia. Am Fam Physician 2015;91:299–307.Suche in Google Scholar
© 2021 Walter de Gruyter GmbH, Berlin/Boston
Artikel in diesem Heft
- Frontmatter
- Minireview
- Can pulse wave velocity (PWV) alone express arterial stiffness? A neglected tool for vascular function assessment
- Review
- Hyponatremia in heart failure: not just 135 to 145
- Original Articles
- Effects of berberine on cholinesterases and monoamine oxidase activities, and antioxidant status in the brain of streptozotocin (STZ)-induced diabetic rats
- Paradoxical sleep deprivation induces oxidative stress in the submandibular glands of Wistar rats
- Terminalia arjuna supplementation ameliorates high fat diet-induced oxidative stress in nephrotoxic rats
- Decreased expression of annexin A2 and loss of its association with vascular endothelial growth factor leads to the deficient trophoblastic invasion in preeclampsia
- Algogen-induced vasosensory reflexes modulate short-term heart rate variability parameters in experimental rat models
- Assessment of sleep quality and its predictors among newly diagnosed psychiatric patients
- Ovalbumin/lipopolysaccharide induced vasculitis in rats: a new predictive model
- Dose-dependent and time-dependent metabolic, hemodynamic, and redox disturbances in dexamethasone-treated Wistar rats
- Effects of sleeve gastrectomy on neutrophil–lymphocyte ratio
- Effect of luteolin on the gene level expression of apoptosis-associated speck-like protein containing a caspase recruitment domain of NLRP3 inflammasome and NF-κB in rats subjected to experimental pancreatitis – influence of HSP70
- Effects of Onosma dichroanthum Boiss. root extract on AGS human gastric cancer cell-line
- Feasibility, face, and content validity of quantitative computed tomography in interstitial lung disease related to connective tissue diseases
- In vitro anticoagulant activity of selected medicinal plants: potential interactions with warfarin and development of new anticoagulants
- Normal reference value of orthodromic and antidromic sensory nerve conduction velocity of median nerve with intact palmaris longus tendon in apparently healthy individuals
- Short Communication
- Chemokine receptor antagonists with α1-adrenergic receptor blocker activity
Artikel in diesem Heft
- Frontmatter
- Minireview
- Can pulse wave velocity (PWV) alone express arterial stiffness? A neglected tool for vascular function assessment
- Review
- Hyponatremia in heart failure: not just 135 to 145
- Original Articles
- Effects of berberine on cholinesterases and monoamine oxidase activities, and antioxidant status in the brain of streptozotocin (STZ)-induced diabetic rats
- Paradoxical sleep deprivation induces oxidative stress in the submandibular glands of Wistar rats
- Terminalia arjuna supplementation ameliorates high fat diet-induced oxidative stress in nephrotoxic rats
- Decreased expression of annexin A2 and loss of its association with vascular endothelial growth factor leads to the deficient trophoblastic invasion in preeclampsia
- Algogen-induced vasosensory reflexes modulate short-term heart rate variability parameters in experimental rat models
- Assessment of sleep quality and its predictors among newly diagnosed psychiatric patients
- Ovalbumin/lipopolysaccharide induced vasculitis in rats: a new predictive model
- Dose-dependent and time-dependent metabolic, hemodynamic, and redox disturbances in dexamethasone-treated Wistar rats
- Effects of sleeve gastrectomy on neutrophil–lymphocyte ratio
- Effect of luteolin on the gene level expression of apoptosis-associated speck-like protein containing a caspase recruitment domain of NLRP3 inflammasome and NF-κB in rats subjected to experimental pancreatitis – influence of HSP70
- Effects of Onosma dichroanthum Boiss. root extract on AGS human gastric cancer cell-line
- Feasibility, face, and content validity of quantitative computed tomography in interstitial lung disease related to connective tissue diseases
- In vitro anticoagulant activity of selected medicinal plants: potential interactions with warfarin and development of new anticoagulants
- Normal reference value of orthodromic and antidromic sensory nerve conduction velocity of median nerve with intact palmaris longus tendon in apparently healthy individuals
- Short Communication
- Chemokine receptor antagonists with α1-adrenergic receptor blocker activity
